Dobrovolskaia MA - Search Results

1

Induction of Cytokines by Nucleic Acid Nanoparticles (NANPs) Depends on the Type of Delivery Carrier.

Avila YI, Chandler M, Cedrone E, Newton HS, Richardson M, Xu J, Clogston JD, Liptrott NJ, Afonin KA, Dobrovolskaia MA. Avila YI, et al. Among authors: dobrovolskaia ma. Molecules. 2021 Jan 27;26(3):652. doi: 10.3390/molecules26030652. Molecules. 2021. PMID: 33513786 Free PMC article.

2

Method for analysis of nanoparticle hemolytic properties in vitro.

Dobrovolskaia MA, Clogston JD, Neun BW, Hall JB, Patri AK, McNeil SE. Dobrovolskaia MA, et al. Nano Lett. 2008 Aug;8(8):2180-7. doi: 10.1021/nl0805615. Epub 2008 Jul 8. Nano Lett. 2008. PMID: 18605701 Free PMC article.

3

Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles.

Dobrovolskaia MA, Patri AK, Zheng J, Clogston JD, Ayub N, Aggarwal P, Neun BW, Hall JB, McNeil SE. Dobrovolskaia MA, et al. Nanomedicine. 2009 Jun;5(2):106-17. doi: 10.1016/j.nano.2008.08.001. Epub 2008 Dec 13. Nanomedicine. 2009. PMID: 19071065 Free PMC article.

4

Ambiguities in applying traditional Limulus amebocyte lysate tests to quantify endotoxin in nanoparticle formulations.

Dobrovolskaia MA, Neun BW, Clogston JD, Ding H, Ljubimova J, McNeil SE. Dobrovolskaia MA, et al. Nanomedicine (Lond). 2010 Jun;5(4):555-62. doi: 10.2217/nnm.10.29. Nanomedicine (Lond). 2010. PMID: 20528451 Free PMC article.

5

Design and self-assembly of siRNA-functionalized RNA nanoparticles for use in automated nanomedicine.

Afonin KA, Grabow WW, Walker FM, Bindewald E, Dobrovolskaia MA, Shapiro BA, Jaeger L. Afonin KA, et al. Among authors: dobrovolskaia ma. Nat Protoc. 2011 Dec 1;6(12):2022-34. doi: 10.1038/nprot.2011.418. Nat Protoc. 2011. PMID: 22134126 Free PMC article.

6

Common pitfalls in nanotechnology: lessons learned from NCI's Nanotechnology Characterization Laboratory.

Crist RM, Grossman JH, Patri AK, Stern ST, Dobrovolskaia MA, Adiseshaiah PP, Clogston JD, McNeil SE. Crist RM, et al. Among authors: dobrovolskaia ma. Integr Biol (Camb). 2013 Jan;5(1):66-73. doi: 10.1039/c2ib20117h. Integr Biol (Camb). 2013. PMID: 22772974 Free PMC article.

7

Inhibition of phosphoinositol 3 kinase contributes to nanoparticle-mediated exaggeration of endotoxin-induced leukocyte procoagulant activity.

Ilinskaya AN, Man S, Patri AK, Clogston JD, Crist RM, Cachau RE, McNeil SE, Dobrovolskaia MA. Ilinskaya AN, et al. Among authors: dobrovolskaia ma. Nanomedicine (Lond). 2014 Jul;9(9):1311-26. doi: 10.2217/nnm.13.137. Epub 2013 Nov 27. Nanomedicine (Lond). 2014. PMID: 24279459 Free PMC article.

8

Choice of method for endotoxin detection depends on nanoformulation.

Dobrovolskaia MA, Neun BW, Clogston JD, Grossman JH, McNeil SE. Dobrovolskaia MA, et al. Nanomedicine (Lond). 2014;9(12):1847-56. doi: 10.2217/nnm.13.157. Epub 2013 Dec 20. Nanomedicine (Lond). 2014. PMID: 24359551

9

Sterilization of Silver Nanoparticles Using Standard Gamma Irradiation Procedure Affects Particle Integrity and Biocompatibility.

Zheng J, Clogston JD, Patri AK, Dobrovolskaia MA, McNeil SE. Zheng J, et al. Among authors: dobrovolskaia ma. J Nanomed Nanotechnol. 2011 Oct 25;2011(Suppl 5):001. doi: 10.4172/2157-7439.S5-001. J Nanomed Nanotechnol. 2011. PMID: 25035814 Free PMC article.

10

Triggering of RNA interference with RNA-RNA, RNA-DNA, and DNA-RNA nanoparticles.

Afonin KA, Viard M, Kagiampakis I, Case CL, Dobrovolskaia MA, Hofmann J, Vrzak A, Kireeva M, Kasprzak WK, KewalRamani VN, Shapiro BA. Afonin KA, et al. Among authors: dobrovolskaia ma. ACS Nano. 2015 Jan 27;9(1):251-9. doi: 10.1021/nn504508s. Epub 2014 Dec 18. ACS Nano. 2015. PMID: 25521794 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

145 results

Search Page